09 Aug 2022

Vifor Pharma AG : Takeover (Update as of 09 August 2022)

In a media release dated 02 August 2022, CSL Ltd announced that the voluntary takeover offer for Vifor Pharma AG has been consummated. Accordingly, as described in previous Corporate Action Info and pursuant to the Contract Specifications for Futures Contracts and Options Contracts at Eurex Deutschland, existing positions will be settled at the theoretical fair value. Basis for the calculation of the fair values is the tender offer price of CHF 171,58 per share. (ECB fixings as of 08.08.2022)

More information about the offer is available on website www.vifor.com

The final settlement prices for the options and futures contracts with open interest are given in the table below.
09 August 2022, all participants with open positions will receive an information containing an overview of their respective open positions. Resulting cash balances will be booked on 09 August 2022, with value date 10 August 2022. (value date for settlement prices is 08.08.2022) In the end-of-day processing on 10 August 2022, any open positions will be booked out effective 11 August 2022.

Trading in the above mentioned contracts have been discontinued.


Market Status


The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.

We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.

An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.